- ICH GCP
- US Clinical Trials Registry
- Researchers
- France
- Pancreatic Neoplasms
Medical specialists from France tagged as investigators in clinical trials studying Pancreatic Neoplasms
Total 193 results
-
Abderrezak LADOUANISeen in:
- Osny, CH Privé Sainte Marie
Trials:- NCT03693677 (Sub-Investigator)
Conditions: -
Adina MARTISeen in:
- Auxerre, CH
Trials:- NCT03693677 (Sub-Investigator)
Conditions: -
Adrien MELISSeen in:
- Chalon-sur-Saône, Hopital Prive Sainte Marie
Trials:- NCT03693677 (Principal Investigator)
Conditions: -
Agnès VIMAL-BAGUETSeen in:
- Clermont-Ferrand, CHU Estaing
Trials:- NCT03693677 (Sub-Investigator)
Conditions: -
Ahmet AYAV, PrSeen in:
- Nancy, Centre Hospitalier Universitaire de Nancy
Trials:- NCT02818907 (Principal Investigator)
Conditions: -
Albert ALEBASeen in:
- Niort, CH
Trials:- NCT03693677 (Principal Investigator)
Conditions: -
Alexandra LAPEYRE-PROSTSeen in:
- Paris, Hôpital Européen Georges Pompidou
Trials:- NCT03693677 (Sub-Investigator)
Conditions: -
Ali Reza KIANMANESH, PrSeen in:
- Reims, Centre Hospitalier universitaire Robert Debré
Trials:- NCT02818907 (Principal Investigator)
Conditions: -
Alice GAGNAIRESeen in:
- Dijon, CHU
- Dijon, CHU - Hôpital François Mitterand
Trials:- NCT03693677 (Sub-Investigator)
- NCT02885753 (Sub-Investigator)
Conditions: -
Alice GANGLOFFSeen in:
- Rouen, CHU Charles Nicolle
Trials:- NCT03693677 (Sub-Investigator)
Conditions: -
Amalia TOPOLSCKISeen in:
- Colmar, Hôpitaux civils de Colmar
Trials:- NCT03693677 (Sub-Investigator)
Conditions: -
Amandine BeronSeen in:
- Lille, CHRU de Lile
Trials:- NCT05477576 (Principal Investigator)
-
Angelique VienotSeen in:
- Besancon, Centre Hospitalier Régional Universitaire de Besançon
- Besancon, University Hospital of Besancon
- Bourgogne-Franche-Comte, Besançon, Center Hospitalier Regional Universitaire de Besancon - Site Jean Minjoz
Trials:- NCT03678883 (Principal Investigator)
- NCT03974854 (Principal Investigator)
- NCT05948475 (Principal Investigator)
Conditions:- Sarcoma;
- Cancer;
- Breast Neoplasms;
- Neoplasm Metastasis;
- Pancreatic Neoplasms;
- Pancreatic Cancer;
- Pancreatic Adenocarcinoma;
- Bone Cancer;
- Malignant Glioma;
- Bone Metastases;
- Pancreas Cancer;
- Renal Cancer;
- Refractory Non-Hodgkin Lymphoma;
- Bone Neoplasm;
- Neoplasm, Breast;
- Refractory Cancer;
- Refractory Neoplasm;
- Resistant Cancer;
- Neoplasm of Bone;
- Neoplasm of Lung;
- Neoplasms,Colorectal;
- Neoplasms Pancreatic;
- Malignancies;
- Malignancies Multiple;
- Acute T Cell Leukemia Lymphoma;
- Metastatic Pancreatic Adenocarcinoma;
- Cholangiocarcinoma
-
Anne GUILNGARSeen in:
- Bayonne CEDEX, CH - Côte Basque
- Bayonne, CH de la côte Basque
Trials:- NCT03693677 (Sub-Investigator)
- NCT02885753 (Sub-Investigator)
Conditions: -
Anne PlaquinnSeen in:
- Lille Cedex, Centre Hospitalier Regional Universitaire de Lille
Trials:- NCT05945823 (Principal Investigator)
-
Anne Ploquin, MDSeen in:
- Hauts De France, Lille, Hôpital Claude Huriez
- Lille, Hôpital Claude Huriez - Oncologie médicale
Trials:- NCT03678883 (Principal Investigator)
- NCT04811703 (Principal Investigator)
Conditions:- Sarcoma;
- Cancer;
- Breast Neoplasms;
- Neoplasm Metastasis;
- Pancreatic Neoplasms;
- Pancreatic Cancer;
- Pancreatic Adenocarcinoma;
- Bone Cancer;
- Malignant Glioma;
- Bone Metastases;
- Pancreas Cancer;
- Renal Cancer;
- Refractory Non-Hodgkin Lymphoma;
- Bone Neoplasm;
- Neoplasm, Breast;
- Refractory Cancer;
- Refractory Neoplasm;
- Resistant Cancer;
- Neoplasm of Bone;
- Neoplasm of Lung;
- Neoplasms,Colorectal;
- Neoplasms Pancreatic;
- Malignancies;
- Malignancies Multiple;
- Acute T Cell Leukemia Lymphoma;
- Peritoneal Carcinomatosis;
- Stage IV Fallopian Tube Cancer;
- Stage IV Ovarian Cancer;
- Metastatic Ovarian Carcinoma;
- Metastatic Malignant Neoplasm in the Peritoneum;
- Stage III Ovarian Cancer;
- Stage III Fallopian Tube Cancer
-
Anne THIROT BIDAULTSeen in:
- Antony, Hôpital privé
Trials:- NCT03693677 (Principal Investigator)
Conditions: -
Anne-Claire HARDY BESSARDSeen in:
- Plérin, Centre Cario HPCA
Trials:- NCT03693677 (Sub-Investigator)
Conditions: -
Anne-Laure VILLINGSeen in:
- Auxerre, CH
- Auxerre, Ch - Ght Unyon Auxerre
Trials:- NCT03693677 (Principal Investigator)
- NCT03760822 (Principal Investigator)
-
Anthony LOPEZSeen in:
- Vandœuvre-lès-Nancy, CHRU de Nancy
Trials:- NCT03693677 (Principal Investigator)
Conditions: -
Antoine BRUNASeen in:
- Osny, CH Privé Sainte Marie
Trials:- NCT03693677 (Sub-Investigator)
Conditions: -
Antoine DROUILLARDSeen in:
- Dijon, CHU
- Dijon, CHU Francois Mitterrand
Trials:- NCT04169841 (Principal Investigator)
- NCT03693677 (Principal Investigator)
Conditions: -
Antoine Hollebecque, MDSeen in:
- Paris, Institut Gustave Roussy
- Villejuif, Gustave Roussy
Trials:- NCT02912949 (Principal Investigator)
- NCT03526835 (Principal Investigator)
- NCT05615818 (Principal Investigator)
Conditions: -
Ariane DARUT-JOUVESeen in:
- Dijon, Institut de Cancérologie de Bourgogne
- Dijon, Institut de Cancérologie de Bourgogne - GRReCC
Trials:- NCT05254639 (Principal Investigator)
- NCT03693677 (Principal Investigator)
Conditions: -
Audrey HENNEQUINSeen in:
- Dijon, Centre GF Leclerc
- Dijon, Centre Georges François Leclerc
Trials:- NCT04675320 (Sub-Investigator)
- NCT03693677 (Sub-Investigator)
Conditions: -
Aurelien LambertSeen in:
- Meurthe-et-Moselle, Vandœuvre-lès-Nancy, Institute de Cancérologie de Lorraine
Trials:- NCT03678883 (Principal Investigator)
Conditions:- Sarcoma;
- Cancer;
- Breast Neoplasms;
- Neoplasm Metastasis;
- Pancreatic Neoplasms;
- Pancreatic Cancer;
- Pancreatic Adenocarcinoma;
- Bone Cancer;
- Malignant Glioma;
- Bone Metastases;
- Pancreas Cancer;
- Renal Cancer;
- Refractory Non-Hodgkin Lymphoma;
- Bone Neoplasm;
- Neoplasm, Breast;
- Refractory Cancer;
- Refractory Neoplasm;
- Resistant Cancer;
- Neoplasm of Bone;
- Neoplasm of Lung;
- Neoplasms,Colorectal;
- Neoplasms Pancreatic;
- Malignancies;
- Malignancies Multiple;
- Acute T Cell Leukemia Lymphoma
-
Aziz ZAANANSeen in:
- Paris, CHU - Hôpital Européen George Pompidou
- Paris, HEGP
- Paris, Hôpital Européen Georges Pompidou
Trials:- NCT02355379 (Sub-Investigator)
- NCT03693677 (Sub-Investigator)
- NCT02885753 (Sub-Investigator)
-
Bastien DIRRENBERGENSeen in:
- Vandœuvre-lès-Nancy, CHRU de Nancy
Trials:- NCT03693677 (Sub-Investigator)
Conditions: -
Bruno HEYD, PrSeen in:
- Besançon, Centre Hospitalier Régional Universitaire de Besançon
Trials:- NCT02818907 (Principal Investigator)
Conditions: -
Bruno LANDISeen in:
- Paris, HEGP
- Paris, Hôpital Européen Georges Pompidou
Trials:- NCT02355379 (Sub-Investigator)
- NCT03693677 (Sub-Investigator)
Conditions:
Clinical Trials on Pancreatic Neoplasms
-
City of Hope Medical CenterRecruitingPancreatic Neoplasms | Pancreatic Cancer | Pancreatic Adenocarcinoma | Pancreatic Ductal Adenocarcinoma | Pancreatic Cancer Resectable | Pancreatic Carcinoma | Pancreatic Cancer Non-resectable | Pancreatic Cancer Stage III | Pancreatic Cancer Stage | Pancreatic Cancer Stage II | Pancreatic Cancer, Adult | Pancreatic... and other conditionsKorea, Republic of, United States, Japan
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CelgeneWithdrawnPancreatic Ductal Adenocarcinoma | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingPancreatic Cancer | Pancreatic Cancer Metastatic | Pancreatic Cancer Stage IV | Metastatic Pancreatic Carcinoma | Metastatic Pancreatic Adenocarcinoma | Pancreatic Carcinoma | Metastatic Pancreatic Cancer | Pancreatic Cancer Non-resectable | Metastatic Pancreatic Ductal Adenocarcinoma | Pancreatic Carcinoma... and other conditionsUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedPancreatic Adenocarcinoma | Resectable Pancreatic Cancer | Stage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic Cancer | Poorly Differentiated Malignant Neoplasm | Undifferentiated Pancreatic CarcinomaUnited States
-
The First Affiliated Hospital with Nanjing Medical...RecruitingLocally Advanced Pancreatic Adenocarcinoma | Metastatic Pancreatic Cancer | Pancreatic NeoplasmChina
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnStage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic Cancer
-
National Cancer Institute (NCI)CompletedStage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
University of UtahNovartis PharmaceuticalsRecruitingMetastatic Pancreatic Carcinoma | Unresectable Pancreatic Carcinoma | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage II Pancreatic CancerUnited States
-
University of OxfordNational Institute for Health Research, United Kingdom; ImunonWithdrawnPancreatic Cancer Metastatic | Pancreatic Ductal Adenocarcinoma | Pancreatic Cancer Stage IV | Pancreatic Cancer Non-resectableUnited Kingdom
-
Mayo ClinicNational Cancer Institute (NCI)CompletedAdvanced Pancreatic Carcinoma | Metastatic Pancreatic Carcinoma | Stage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Unresectable Pancreatic Carcinoma | Pancreatic Neoplasm | Locally Advanced Pancreatic CarcinomaUnited States